These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25645584)

  • 1. Microvessel density analysis in patients with viral hepatitis-related hepatocellular carcinoma.
    Mohamed A; Chenna A; Abdelfatah M; Sanjay J; Mohammad MK; Saber I; Kauh J; Elhammali B; Kaseb A
    J Gastrointest Cancer; 2015 Jun; 46(2):104-8. PubMed ID: 25645584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma.
    Messerini L; Novelli L; Comin CE
    J Clin Pathol; 2004 Aug; 57(8):867-71. PubMed ID: 15280410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of influence of cyclooxygenese-2 expression in hepatocellular carcinomas on patient survival.
    Yildirim Y; Ozyilkan O; Bilezikci B; Akcali Z; Haberal M
    Asian Pac J Cancer Prev; 2008; 9(2):295-8. PubMed ID: 18712978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B Infection.
    Omichi K; Shindoh J; Yamamoto S; Matsuyama Y; Akamatsu N; Arita J; Kaneko J; Sakamoto Y; Hasegawa K; Kokudo N
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1034-40. PubMed ID: 26350363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
    Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
    Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study.
    Poon RT; Ng IO; Lau C; Yu WC; Yang ZF; Fan ST; Wong J
    J Clin Oncol; 2002 Apr; 20(7):1775-85. PubMed ID: 11919234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density of hepatocellular carcinoma: its relationship with prognosis.
    Sun HC; Tang ZY; Li XM; Zhou YN; Sun BR; Ma ZC
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):419-26. PubMed ID: 10394963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
    Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
    Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
    BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma].
    Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM
    Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma.
    Yamamoto A; Dhar DK; El-Assal ON; Igarashi M; Tabara H; Nagasue N
    J Hepatol; 1998 Aug; 29(2):290-9. PubMed ID: 9722211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance.
    Tanigawa N; Lu C; Mitsui T; Miura S
    Hepatology; 1997 Nov; 26(5):1216-23. PubMed ID: 9362365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.
    Mazzanti R; Messerini L; Comin CE; Fedeli L; Ganne-Carrie N; Beaugrand M
    World J Gastroenterol; 2007 Oct; 13(37):5009-14. PubMed ID: 17854145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma.
    Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H
    Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumoral α-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer.
    Wang WQ; Liu L; Xu HX; Luo GP; Chen T; Wu CT; Xu YF; Xu J; Liu C; Zhang B; Long J; Tang ZY; Yu XJ
    PLoS One; 2013; 8(8):e71189. PubMed ID: 23940715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
    Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
    World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus.
    Chen ZB; Shen SQ; Ding YM; Wang WX; Tao JP; Liang LJ; Hu WJ
    Med Oncol; 2009; 26(3):365-71. PubMed ID: 19082771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.